Overview

Antibiotic Prophylaxis in Bariatric Surgery With Cefazolin: Concentration in Adipose Tissue

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
0
Participant gender:
All
Summary
Eighteen patients were given a dose of 2g Cefazolin in anesthetic induction, supplemented with 1g delivered through continuous infusion during surgery. Adipose samples, obtained at the beginning and end of surgery, were analyzed using high performance liquid chromatography. Some published studies suggest that the dose of 2g does not supply the minimum inhibitory concentration for principal causal agents of surgical site infection. To determine the concentration of Cefazolin in adipose tissue of patients undergoing bariatric surgery and to evaluate the relationship between concentrations obtained and body mass index (BMI).
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Universidade Federal de Pernambuco
Treatments:
Anti-Bacterial Agents
Anti-Infective Agents
Cefazolin
Criteria
Inclusion Criteria:

- body mass index greater than 35 and less than 50kg/m2

Exclusion Criteria:

- Hypotension during surgery with use of vasoactive drugs

- renal disfunction (creatinine >1.5 mg/dL)